Trials / Completed

CompletedNCT00035217

Follow-Up Study for Men Diagnosed With Prostate Cancer Through Participation in a Prostate Specific Antigen Screening Program

Follow-Up Study for Men Diagnoses With Prostate Cancer Through Participation in a Prostate Specific Antigen Screening Program

Status: Completed
Phase: —
Study type: Observational
Enrollment: —

Sponsor: National Center for Research Resources (NCRR) · NIH
Sex: Male
Age: 40 Years
Healthy volunteers: Not accepted

Summary

There is controversy concerning the preferred treatment for men with localized prostate cancer with regard to the relative effectiveness of different treatments in controlling the cancer and how different treatments affect the patient's quality of life. The purpose of this research is to describe the disease course of prostate cancer and to determine the effectiveness, potential complications, and quality of life after different treatments in men with prostate cancer detected via screening with prostate-specific antigen (PSA) and/or digital rectal examination

Conditions

Prostate Cancer

Timeline

First posted: 2002-05-03
Last updated: 2005-06-24

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00035217. Inclusion in this directory is not an endorsement.